Nelarabine

Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM: weakly inhibits KDR and Src, no significant inhibition to Akt, CDK1/2/4, IKK-2, MK-2, PDK1, c-Raf and c-Met. Phase 3.A potent and selective inhibitor of

Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM: weakly inhibits KDR and Src, no significant inhibition to Akt, CDK1/2/4, IKK-2, MK-2, PDK1, c-Raf and c-Met. Phase 3.A potent and selective inhibitor of

Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM: weakly inhibits KDR and Src, no significant inhibition to Akt, CDK1/2/4, IKK-2, MK-2, PDK1, c-Raf and c-Met. Phase 3.A potent and selective inhibitor of

Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM: weakly inhibits KDR and Src, no significant inhibition to Akt, CDK1/2/4, IKK-2, MK-2, PDK1, c-Raf and c-Met. Phase 3.A potent and selective inhibitor of

Neutrase® 0.8 L.

Neutrase® 0.8 L.

Neutrase® 0.8 L.

nezulcitinib.

nezulcitinib.

A standard formulation for use in Nematode growth studies. Contains: Agar 17.5 g/l Sodium Chloride 3.0 g/l Peptone 2.5 g/l Cholesterol 0.005 g/l

A standard formulation for use in Nematode growth studies. Contains: Agar 17.5 g/l Sodium Chloride 3.0 g/l Peptone 2.5 g/l Cholesterol 0.005 g/l

A 21 mL concentrate for determination of Amenable and Total Cyanide. Formulated in the NELAC range of 0.1 - 1 mg/L. Each ampule produces 2 liters of sample. (Supplied in duplicate)